E-LIB Suche - Ergebnisse für: Kallend, David

1

Effect of lipid-lowering therapies on C-reactive protein le..:

Xie, Sining ; Galimberti, Federica ; Olmastroni, Elena...
Cardiovascular Research. 120 (2024) 4 - p. 333-344 , 2024

Link: https://doi.org/10.1093/..

2

Long-term efficacy and safety of lerodalcibep in heterozygo..:

Raal, Frederick ; Fourie, Nyda ; Scott, Russell...
European Heart Journal. 44 (2023) 40 - p. 4272-4280 , 2023

Link: https://doi.org/10.1093/..

3

The N‐Acetylgalactosamine‐conjugated small interfering RNA ..:

Lehoux, Dario ; Kallend, David ; Wijngaard, Peter L. J...
Pharmacology Research & Perspectives. 11 (2023) 2 - p. , 2023

Link: https://doi.org/10.1002/..

4

Evaluation of the distribution and excretion of [14C]-incli..:

Lehoux, Dario ; Far, Adel Rafai ; Kallend, David..
Toxicology and Applied Pharmacology. 443 (2022) - p. 115978 , 2022

Link: https://doi.org/10.1016/..

5

Effect of inclisiran on lipids in primary prevention: the O..:

Ray, Kausik K ; Kallend, David ; Leiter, Lawrence A...
European Heart Journal. 43 (2022) 48 - p. 5047-5057 , 2022

Link: https://doi.org/10.1093/..

6

†Efficacy and Safety of Inclisiran in Patients with Polyvas..:

Ray, Kausik ; Kallend, David ; Landmesser, Ulf...
Journal of Clinical Lipidology. 16 (2022) 3 - p. e63 , 2022

Link: https://doi.org/10.1016/..

7

†Efficacy and Safety of Inclisiran in Patients with Establi..:

Ray, Kausik ; Kallend, David ; Landmesser, Ulf...
Journal of Clinical Lipidology. 16 (2022) 3 - p. e65 , 2022

Link: https://doi.org/10.1016/..

8

Corrigendum to "Evaluation of the distribution and excretio..:

Lehoux, Dario ; Far, Adel Rafai ; Kallend, David..
Toxicology and Applied Pharmacology. 451 (2022) - p. 116144 , 2022

Link: https://doi.org/10.1016/..

9

An evaluation of a supratherapeutic dose of inclisiran on c..:

Kallend, David ; Mason, Jay ; Smith, Patrick F....
Clinical and Translational Science. 15 (2022) 11 - p. 2663-2672 , 2022

Link: https://doi.org/10.1111/..

10

Pharmacokinetics and pharmacodynamics of inclisiran, a smal..:

Kallend, David ; Stoekenbroek, Robert ; He, YanLing..
Journal of Clinical Lipidology. 16 (2022) 2 - p. 208-219 , 2022

Link: https://doi.org/10.1016/..

11

459 Evaluation of LDL-C reductions by siRNA treatment with ..:

Wright, R. Scott ; Kallend, David ; Ray, Kausik K...
European Heart Journal Supplements. 23 (2021) Supplement_G - p. , 2021

Link: https://doi.org/10.1093/..

12

Association of high-density lipoprotein particle concentrat..:

Salahuddin, Taufiq ; Kittelson, John ; Tardif, Jean-Claude...
American Heart Journal. 221 (2020) - p. 60-66 , 2020

Link: https://doi.org/10.1016/..

13

Effect of inclisiran, the small-interfering RNA against pro..:

Landmesser, Ulf ; Haghikia, Arash ; Leiter, Lawrence A...
Cardiovascular Research. 117 (2020) 1 - p. 284-291 , 2020

Link: https://doi.org/10.1093/..

14

Aldosterone Does Not Predict Cardiovascular Events Followin..:

Pitts, Reynaria ; Gunzburger, Elise ; Ballantyne, Christie M....
Journal of the American Heart Association. 6 (2017) 1 - p. , 2017

Link: https://doi.org/10.1161/..

15

MILANO-PILOT: will infusing HDL mimetics containing apoA-im..:

Nicholls, Stephen J. ; Puri, Rishi ; Ballantyne, Christie M....
Atherosclerosis. 263 (2017) - p. e11 , 2017

Link: https://doi.org/10.1016/..